Clinical Trial Update: Efficacy and Safety of AQX-1125 in Unstable COPD [Phase 2]

View source ↗

Summary

Phase 2 study of AQX-1125 in unstable COPD completed with reported efficacy and safety results. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AQX-1125

Snippet

Sponsor: Aquinox Pharmaceuticals (Canada) Inc. | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2017-06-12